HealthProves
Home/Fabrikanten/Chain Drug Consortium, LLC
Fabrikant-profiel

Chain Drug Consortium, LLC

Farmaceutisch bedrijf2 producten gevolgd
2
producten gevolgd
48.108
totaal meldingen
64
recalls geregistreerd
67,6%
ernstig algeheel
Producten
2 van 2 getoond
ProductGoedgekeurdMeldingen ↓Top signaalRecalls
—46.895pemphigus64
—1.213branderig gevoel in vulva en vagina0
Recall-geschiedenis · 50 geregistreerd
DatumKlasseRedenBedrijf
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 mei 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
19 dec 2025IIFailed Disintegration Specifications: above the time expected.Sato Pharmaceutical Co., Ltd
2 dec 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dec 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dec 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dec 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dec 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dec 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dec 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
23 jun 2022IICGMP Deviations: product held outside appropriate storage temperature conditions.Family Dollar Stores, Llc.
26 jan 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
26 jan 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
26 jan 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
26 jan 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
26 jan 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
24 jan 2022IIcGMP deviationsUltra Seal Corporation
24 jan 2022IIcGMP deviationsUltra Seal Corporation
28 mei 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
28 mei 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
28 mei 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
28 mei 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
6 nov 2018IIPresence of foreign substance: Product found to contain metal particles.L. Perrigo Company
7 mei 2018IICGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.RIJ Pharmaceutical LLC
7 mei 2018IICGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.RIJ Pharmaceutical LLC
30 mrt 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
30 mrt 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
30 mrt 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
16 apr 2015IIProducts failed the Antimicrobial Effectiveness Test.Tarmac Products, Inc.

Class I = redelijke kans op ernstige schade · Class II = tijdelijk of omkeerbaar · Class III = onwaarschijnlijk schadelijk.

Registratiestatus

Sommige producten van Chain Drug Consortium, LLC zijn niet FDA-geregistreerd voor humaan gebruik. Voor ongeregistreerde stoffen (peptiden, SARMs zonder humane registratie) bestaat geen legitieme leverancier voor humaan gebruik. Het ontbreken van een inkooproute is de veiligheidsinformatie.